Clinical trial
Biokinetics Study of Tc-99m DMSA for Dose Reduction in Pediatric Molecular Imaging
NCT03107195 is registered in ClinicalTrials.gov with Boston Children's Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Biokinetics Study of Tc-99m DMSA for Dose Reduction in Pediatric Molecular Imaging
- Lead sponsor
- Boston Children's Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2017
- Completion date
- October 6, 2021
- Enrollment
- 24 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
renal disease